Antidepressant effects of resveratrol in an animal model of depression

Baumeister, 2007, Prevalence of mental disorders based on general population surveys, Soc Psychiatry Psychiatr Epidemiol, 42, 537, 10.1007/s00127-007-0204-1 Harada, 2011, Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus, J Nutr Biochem, 22, 1150, 10.1016/j.jnutbio.2010.09.016 Woodward, 2013, Major depressive disorder among older African Americans, Caribbean blacks, and non-Hispanic whites: secondary analysis of the National Survey of American Life, Depress Anxiety, 30, 589, 10.1002/da.22041 Delgado, 2000, Role of norepinephrine in depression, J Clin Psychiatry, 61, 5 Blier, 2013, Serotonin and beyond: therapeutics for major depression, Philos Trans R Soc Lond B Biol Sci, 368, 20120536, 10.1098/rstb.2012.0536 Duman, 2000, Neuronal plasticity and survival in mood disorders, Biol Psychiatry, 48, 732, 10.1016/S0006-3223(00)00935-5 Manji, 2001, Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics, Psychopharmacol Bull, 35, 5 Lee, 2002, Stress and depression: possible links to neuron death in the hippocampus, Bipolar Disord, 4, 117, 10.1034/j.1399-5618.2002.01144.x Shah, 2002, Chronic, treatment-resistant depression and right fronto-striatal atrophy, Br J Psychiatry, 180, 434, 10.1192/bjp.180.5.434 Zhao, 2008, Mechanisms and functional implications of adult neurogenesis, Cell, 132, 645, 10.1016/j.cell.2008.01.033 Banasr, 2010, Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole, Mol Psychiatry, 15, 501, 10.1038/mp.2008.106 Hayley, 2013, Neuroplasticity and the next wave of antidepressant strategies, Front Cell Neurosci, 7, 218, 10.3389/fncel.2013.00218 Maes, 2009, The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression, Metab Brain Dis, 24, 27, 10.1007/s11011-008-9118-1 Hurley, 2013, Neuroinflammation, neurodegeneration, and depression, Neurotox Res, 23, 131, 10.1007/s12640-012-9348-1 Mathew, 2008, Novel drugs and therapeutic targets for severe mood disorders, Neuropsychopharmacology, 33, 2080, 10.1038/sj.npp.1301652 Rush, 2003, Research issues in the study of difficult-to-treat depression, Biol Psychiatry, 53, 743, 10.1016/S0006-3223(03)00088-X Rush, 2006, Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am J Psychiatry, 163, 1905, 10.1176/ajp.2006.163.11.1905 Malberg, 2005, Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs, Curr Pharm Des, 11, 145, 10.2174/1381612053382223 Duman, 2006, A neurotrophic model for stress-related mood disorders, Biol Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013 Castren, 2007, Role of neurotrophic factors in depression, Curr Opin Pharmacol, 7, 18, 10.1016/j.coph.2006.08.009 Aydemir, 2006, Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women, Prog Neuropsychopharmacol Biol Psychiatry, 30, 1256, 10.1016/j.pnpbp.2006.03.025 Hurley, 2013, Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF, Behav Brain Res, 239, 27, 10.1016/j.bbr.2012.10.049 Ebrahimi, 2012, Natural polyphenols against neurodegenerative disorders: potentials and pitfalls, Ageing Res Rev, 11, 329, 10.1016/j.arr.2012.01.006 Xu, 2010, Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system, Eur Neuropsychopharmacol, 20, 405, 10.1016/j.euroneuro.2010.02.013 Ogle, 2013, Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review, Gerontology, 59, 23, 10.1159/000342208 Jang, 1997, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275, 218, 10.1126/science.275.5297.218 Bradamante, 2003, Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism, Eur J Pharmacol, 465, 115, 10.1016/S0014-2999(03)01441-9 Acerson, 2013, A new synthesis of 4′-resveratrol esters and evaluation of the potential for anti-depressant activity, Bioorg Med Chem Lett, 23, 2941, 10.1016/j.bmcl.2013.03.046 Ge, 2013, Antidepressant-like effect of resveratrol: involvement of antioxidant effect and peripheral regulation on HPA axis, Pharmacol Biochem Behav, 114–115, 64, 10.1016/j.pbb.2013.10.028 Liu, 2014, Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats, Prog Neuropsychopharmacol Biol Psychiatry, 49, 21, 10.1016/j.pnpbp.2013.10.017 Liu, 2014, Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats, Behav Brain Res, 264, 9, 10.1016/j.bbr.2014.01.039 Pathak, 2013, Natural polyphenols in the management of major depression, Expert Opin Investig Drugs, 22, 863, 10.1517/13543784.2013.794783 Wang, 2013, Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK, Pharmacol Biochem Behav, 112, 104, 10.1016/j.pbb.2013.10.007 Yu, 2013, Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences, J Psychiatr Res, 47, 315, 10.1016/j.jpsychires.2012.10.018 Getachew, 2008, Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains, Pharmacol Biochem Behav, 91, 97, 10.1016/j.pbb.2008.06.016 Getachew, 2010, Alcohol-induced depressive-like behavior is associated with cortical norepinephrine reduction, Pharmacol Biochem Behav, 96, 395, 10.1016/j.pbb.2010.06.011 Hauser, 2011, Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF, Pharmacol Biochem Behav, 100, 253, 10.1016/j.pbb.2011.08.014 Tizabi, 2010, Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats, Prog Neuropsychopharmacol Biol Psychiatry, 34, 62, 10.1016/j.pnpbp.2009.09.024 Vinod, 2012, Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats, PLoS ONE, 7, e36743, 10.1371/journal.pone.0036743 Okamoto, 1963, Development of a strain of spontaneously hypertensive rats, Jpn Circ J, 27, 282, 10.1253/jcj.27.282 Pare, 1994, Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats, Physiol Behav, 55, 433, 10.1016/0031-9384(94)90097-3 Lopez-Rubalcava, 2000, Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test, Neuropsychopharmacology, 22, 191, 10.1016/S0893-133X(99)00100-1 Tejani-Butt, 2003, Strain-dependent modification of behavior following antidepressant treatment, Prog Neuropsychopharmacol Biol Psychiatry, 27, 7, 10.1016/S0278-5846(02)00308-1 Will, 2003, Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants, Mol Psychiatry, 8, 925, 10.1038/sj.mp.4001345 Akinfiresoye, 2013, Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR, Psychopharmacology (Berl), 230, 291, 10.1007/s00213-013-3153-2 Tizabi, 2012, Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar–Kyoto rats, Neuroscience, 213, 72, 10.1016/j.neuroscience.2012.03.052 Porsolt, 1977, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266, 730, 10.1038/266730a0 Moreau, 1992, Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats, Eur Neuropsychopharmacol, 2, 43, 10.1016/0924-977X(92)90035-7 Tizabi, 1999, Antidepressant effects of nicotine in an animal model of depression, Psychopharmacology (Berl), 142, 193, 10.1007/s002130050879 Masi, 2011, The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression, CNS Drugs, 25, 913, 10.2165/11595900-000000000-00000 Piccinni, 2008, Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments, J Affect Disord, 105, 279, 10.1016/j.jad.2007.05.005 Balu, 2008, Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments, Brain Res, 1211, 37, 10.1016/j.brainres.2008.03.023 Anderson, 2013, Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications, Curr Pharm Des Zhang, 2013, Resveratrol protects cortical neurons against microglia-mediated neuroinflammation, Phytother Res, 27, 344, 10.1002/ptr.4734